Cowen and Company’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Cowen and Company’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-12,500	Closed	-$31K	–	884
2021 Q3	$31K	Buy	+12,500	New	+$345K	﹤0.01%	441
2021 Q2	–	Sell	-10,000	Closed	-$35K	–	825
2021 Q1	$35K	Buy	+10,000	New	+$255K	﹤0.01%	418
2020 Q4	–	Sell	-15,000	Closed	-$6K	–	574
2020 Q3	$6K	Buy	+15,000	New	+$311K	﹤0.01%	410

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Cowen and Company's DRNA Position: Q4 2021 in Review

Cowen and Company sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 2,514 shares — an estimated $51K sold.

Cowen and Company first reported a position in DRNA in Q3 2020 and held it in 2 quarters. The position peaked at $128K in Q3 2020. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Cowen and Company reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Cowen and Company sold 2,514 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $51K.
Cowen and Company first reported a position in Dicerna Pharmaceuticals, Inc. in Q3 2020 and held it in 2 quarters.
Cowen and Company's Dicerna Pharmaceuticals, Inc. position peaked at $128K in Q3 2020.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Cowen and Company's 13F filing for Q4 2021, filed 14 Feb 2022.